Dan Sztybel

Senior Advisor - Digital Health

 

Prior to joining Blue Stream Partners, Dan led the Life Science and Healthcare Advisory Team at EY (Ernst & Young). There he led the business strategy and funding strategy life sciences, medical device, digital healthcare, and clean-tech companies. In these capacities he managed the evaluation of the companies’ funding needs, locating relevant funding sources in Israel and abroad, and submission of funding applications to relevant granting agencies. His clients have included well known start-ups, established companies, and global pharma for company’s funding strategy and grant application in the European Seventh Framework Programme (FP7). Dan has a strong background in molecular biology/biotechnology and was part of a PhD program in Molecular Genetics at the Weizmann Institute, Israel. Prior to EY, Dan worked as a research scientist at EvoGene and Compugen, and as a IP Patent assistant at Ehrlich & Fenster.

 

Contact Details:

 

Mobile: +972.54.456.1349

Email: dan@bluestreampartners.com